Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-08

Clinical Trial Update: Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

View source ↗

Summary

The clinical trial evaluating mitochondrial dysfunction in Neurofibromatosis type 1 has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arkansas | Conditions: Neurofibromatosis 1 | Status: COMPLETED | Results posted: 2025-05-08